SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* LARSON JOHN RANDOLPH (Last) (First) (Middle) C/O CORAUTUS GENETICS INC. 75 FIFTH STREET, SUITE 313 (Street) ATLANTA GA 30308 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol CORAUTUS GENETICS INC [ CAQ ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 05/07/2004
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/07/2004		P		18,000	A	$5.5	23,482	D
Common Stock								640	I	Held in escrow for reporting person
Common Stock								31,433	I	Partnership controlled by reporting person
Common Stock								3,675	I	Held in escrow for partnership controlled by reporting person

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$5.5	05/07/2004		A		1,000		05/07/2004	05/07/2014	Common Stock	1,000	$0	1,000	D
Stock Option (right to buy)	$5.5	05/07/2004		A		21,000(1)(2)		(1)(2)	05/07/2004	Common Stock	21,000	$0	21,000	D

Explanation of Responses:

1. Of the 21,000 shares, (A) 6,000 shares were awarded to the director as a retainer grant for the upcoming service year, which shall become 100% exercisable on the last day of the service year if the director continues to serve through that date; (B) 6,000 shares were awarded to the director as compensation for attendance at board meetings during the upcoming service year, which shall become first exercisable on the last day of the service year in 1,500 share quadrants for attendance at each of Corautus' board meetings at any time during the service year; (C) 3,000 shares were awarded as compensation to the director for attendance at meetings of the Audit Committee of the board for the upcoming service year, which shall first become exercisable on the last day of the service year in 750 share quadrants for attendance at each of four Audit Committee meetings at any time during the service year; (cont'd in footnote 2)

2. (con't from footnote 1) (D) 3,000 shares were awarded as compensation to the director for attendance at meetings of the Nominating and Corporate Governance Committee of the board for the upcoming service year, which shall first become exercisable on the last day of the service year in 750 share quadrants for attendance at each of four Nominating and Corporate Governance Committee meetings at any time during the service year; and (E) 3,000 shares were awarded as compensation to the director for serving as Chairman of the Nominating and Corporate Governance Committee for the upcoming service year, which shall first become exercisable on the last day of the service year in 750 share quadrants for serving as Chairman at each of four Nominating and Corporate Governance Committee meetings at any time during the service year.

Remarks:

	Andrew J. Surdykowski, by power of attorney	05/11/2004
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.